Patent applications and USPTO patent grants for Singh; Shweta.The latest application filed is for "anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof".
Patent | Date |
---|---|
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof App 20220306759 - Sagert; Jason Gary ;   et al. | 2022-09-29 |
Anti-CD38 antibodies Grant 11,434,304 - Elias , et al. September 6, 2 | 2022-09-06 |
Anti-CD38 binding domains Grant 11,414,496 - Elias , et al. August 16, 2 | 2022-08-16 |
Indole-ynone Mediated Benzoannulation Process For The Preparation Of Carbazoles, Carbazomycin A, Calothrixin B And Staurosporinone App 20220169609 - PABBARAJA; Srihari ;   et al. | 2022-06-02 |
Compositions And Methods For Conjugating Activatable Antibodies App 20220088192 - LOWMAN; Henry Bernard ;   et al. | 2022-03-24 |
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof Grant 11,267,896 - Sagert , et al. March 8, 2 | 2022-03-08 |
System and method to recognize unauthenticated visitors Grant 11,240,255 - Amin , et al. February 1, 2 | 2022-02-01 |
Anti-cd71 Activatable Antibody Drug Conjugates And Methods Of Use Thereof App 20210145978 - Singh; Shweta ;   et al. | 2021-05-20 |
Anti-cd166 Antibodies, Activatable Anti-cd166 Antibodies, And Methods Of Use Thereof App 20200291113 - WEST; James William ;   et al. | 2020-09-17 |
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof Grant 10,745,481 - West , et al. A | 2020-08-18 |
Anti-cd38 Binding Domains App 20200231696 - Elias; Kathleen Ann ;   et al. | 2020-07-23 |
Anti-cd38 Antibodies App 20200040105 - Elias; Kathleen Ann ;   et al. | 2020-02-06 |
Conjugated Anti-cd38 Antibodies App 20200031951 - Elias; Kathleen Ann ;   et al. | 2020-01-30 |
C10rf32 Antibodies, And Uses Thereof For Treatment Of Cancer App 20200002416 - COJOCARU; Gady S. ;   et al. | 2020-01-02 |
Anti-CD38 antibodies Grant 10,494,444 - Elias , et al. De | 2019-12-03 |
Anti-itga3 Antibodies, Activatable Anti-itga3 Antibodies, And Methods Of Use Thereof App 20190309072 - SAGERT; Jason Gary ;   et al. | 2019-10-10 |
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof App 20190202927 - Sagert; Jason Gary ;   et al. | 2019-07-04 |
Conjugated anti-CD38 antibodies Grant 10,336,833 - Elias , et al. | 2019-07-02 |
Anti-cd71 Activatable Antibody Drug Conjugates And Methods Of Use Thereof App 20190111150 - SINGH; Shweta ;   et al. | 2019-04-18 |
Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof Grant 10,233,244 - Sagert , et al. | 2019-03-19 |
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof Grant 10,179,817 - Sagert , et al. Ja | 2019-01-15 |
Lipids As Synthetic Vectors To Enhance Antigen Processing And Presentation Ex-vivo In Dendritic Cell Therapy App 20180353599 - Bedu-Addo; Frank ;   et al. | 2018-12-13 |
Anti-cd38 Antibodies App 20180066069 - Elias; Kathleen Ann ;   et al. | 2018-03-08 |
Conjugated Anti-cd38 Antibodies App 20180016349 - ELIAS; Kathleen Ann ;   et al. | 2018-01-18 |
Anti-CD38 antibodies Grant 9,790,285 - Elias , et al. October 17, 2 | 2017-10-17 |
C10rf32 Antibodies, And Uses Thereof For Treatment Of Cancer App 20170233473 - COJOCARU; Gady S. ;   et al. | 2017-08-17 |
Conjugated anti-CD38 antibodies Grant 9,676,869 - Elias , et al. June 13, 2 | 2017-06-13 |
C10RF32 antibodies, and uses thereof for treatment of cancer Grant 9,617,336 - Cojocaru , et al. April 11, 2 | 2017-04-11 |
Compositions And Methods For Conjugating Activatable Antibodies App 20170072067 - Lowman; Henry Bernard ;   et al. | 2017-03-16 |
Compositions and methods for conjugating activatable antibodies Grant 9,517,276 - Lowman , et al. December 13, 2 | 2016-12-13 |
Anti-cd166 Antibodies, Activatable Anti-cd166 Antibodies, And Methods Of Use Thereof App 20160355587 - West; James William ;   et al. | 2016-12-08 |
Anti-itga3 Antibodies, Activatable Anti-itga3 Antibodies, And Methods Of Use Thereof App 20160355592 - Sagert; Jason Gary ;   et al. | 2016-12-08 |
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof App 20160355599 - Sagert; Jason Gary ;   et al. | 2016-12-08 |
Conjugated Anti-cd38 Antibodies App 20150291702 - ELIAS; Kathleen Ann ;   et al. | 2015-10-15 |
Conjugated anti-CD38 antibodies Grant 9,102,744 - Elias , et al. August 11, 2 | 2015-08-11 |
C10rf32 Antibodies, And Uses Thereof For Treatment Of Cancer App 20150158947 - Cojocaru; Gady S. ;   et al. | 2015-06-11 |
Compositions And Methods For Conjugating Activatable Antibodies App 20150005477 - Lowman; Henry Bernard ;   et al. | 2015-01-01 |
Conjugated Anti-cd38 Antibodies App 20140155584 - Elias; Kathleen Ann ;   et al. | 2014-06-05 |
System And Method For Monitoring Food Consumption App 20130280681 - Narayan; Vivek ;   et al. | 2013-10-24 |
Anti-CD38 antibodies Grant 8,362,211 - Elias , et al. January 29, 2 | 2013-01-29 |
Anti-cd38 Antibodies App 20120201827 - Elias; Kathleen Ann ;   et al. | 2012-08-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.